What is the IP Risk Profile in AI Drug Discovery?

Start
The scientific benefits and legal risks of AI-driven drug discovery are consequential. But recent IP law decisions allude to a general concept that IP rights will not be awarded if AI completely or significantly replaces human ingenuity in the creative process….
By: Fenwick & West LLP
Previous Story

Fifth Circuit Rules OFAC Cannot Sanction Tornado Cash: Loper Bright Hamstrings OFAC’s Campaign Against Crypto Laundering

Next Story

Maine Right to Repair Law Poised to Remain in Flux Even After January 2025 Effective Date – Seyfarth’s Future of Automotive Series